Strengthening evidence-based medicine with real-world evidence

This publication has 8 references indexed in Scilit:

• Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England
  The Lancet Healthy Longevity, 2022
• Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe
  Frontiers in Pharmacology, 2022
• Evolving Acceptance and Use of RWE for Regulatory Decision Making on the Benefit/Risk Assessment of a Drug in Japan
  Clinical Pharmacology & Therapeutics, 2021
• When Can We Trust Real‐World Data To Evaluate New Medical Treatments?
  Clinical Pharmacology & Therapeutics, 2021
• Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth
  Clinical Pharmacology & Therapeutics, 2020
• Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness?
  Pharmacoepidemiology and Drug Safety, 2020
• Trial designs using real‐world data: The changing landscape of the regulatory approval process
  Pharmacoepidemiology and Drug Safety, 2019
• Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
  Therapeutic Innovation & Regulatory Science, 2018